HPTX News 24.71 Hyperion Therapeutics Inc (HPTX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hyperion Therapeutics Inc (HPTX) 24.71 $HPTX

Hyperion Therapeutics to Present at the 13th Annual Needham Healthcare Conference
GlobeNewswire - Tue Apr 01, 3:14PM CDT
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 13 Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 10:00 a.m. ET.

Hyperion Therapeutics to Present at the 26th Annual Roth Conference
GlobeNewswire - Fri Mar 07, 9:23AM CST
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 26 Annual Roth Conference on Tuesday, March 11, 2014 at 10:30 a.m. PT.

Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 05, 9:58AM CST
Last week saw companies like Medivation, Arena and VIVUS reporting fourth quarter results. But, the spotlight remained on InterMune with its late-stage data on Esbriet.

AVEO Announces Timing for Conference Call to Discuss Year-End 2013 Financial Results and Provide Strategic Update for 2014
Business Wire - Tue Mar 04, 5:30AM CST
AVEO Oncology (NASDAQ: AVEO) today announced that financial results for the company's fourth quarter and year ended December 31, 2013 will be released after the market closes on Thursday, March 13, 2014. AVEO will host a conference call to discuss the company's financial results as well as provide an update on strategy for 2014 on Thursday, March 13 at 4:30 p.m. (ET). The call can be accessed by dialing 1-866-318-8613 (domestic) or 1-617-399-5132 (international) five minutes prior to the start of the call and providing the passcode 57921892. A replay of the call will be available two hours after the completion of the call and can be accessed by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), providing the passcode 61612931. The replay will be available for two weeks from the date of the live call.

This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Sean Williams, The Motley Fool - Motley Fool - Sat Mar 01, 2:15PM CST
With the  SPDR S&P Biotech Index  up  75% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...

Hyperion Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Thu Feb 27, 3:13PM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today reported net revenue of $18.6 million and $42.2 million for the fourth quarter and full year 2013, respectively. Hyperion's revenues are for sales of its two products for the treatment of urea cycle disorders, RAVICTI (glycerol phenylbutyrate) Oral Liquid, launched on March 1, 2013 and BUPHENYL (sodium phenylbutyrate) Tablets and Powder acquired on May 31, 2013. Adjusted net income for the fourth quarter 2013 was $4.1 million compared to an adjusted net loss of $7.9 million in the fourth quarter of 2012, an increase in net income of $12.0 million. The company ended 2013 with cash, cash equivalents and investments of $118.1 million, an increase of $9.5 million from the prior quarter.

Hyperion Therapeutics to Present at the Cowen and Company 34th Annual Healthcare Conference
GlobeNewswire - Wed Feb 26, 3:09PM CST
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Cowen and Company 34 Annual Healthcare Conference on Monday, March 3 at 2:50 p.m. ET.

Why Hyperion Therapeutics Inc. Shares Popped
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 25, 12:59PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Hyperion Therapeutics , a...

Nasdaq stocks posting largest percentage increases
AP - Tue Feb 25, 12:28PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Hyperion Therapeutics Announces the Publication of Phase 2 Results of Glycerol Phenylbutyrate (GPB) for the Treatment of Hepatic Encephalopathy in Hepatology
GlobeNewswire - Tue Feb 25, 9:25AM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that results of the Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of hepatic encephalopathy (HE) were published in the March 2014 issue of Hepatology. The study met its primary endpoint with significantly fewer patients treated with GPB experiencing HE events as compared to patients receiving placebo.

Zhejiang Giuseppe Garment Digs for New Customers
SinoCast - Tue Feb 25, 4:54AM CST
Zhejiang Giuseppe Garment Co., Ltd. (SZSE: 002687) revealed declining sales revenue affected by dim garment market situation in 2013. Hence, the company planned to extend customers from finance, power, and tobacco to private school and government fields.

Hyperion Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results After Market on February 27, 2014
GlobeNewswire - Mon Feb 24, 3:05PM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report fourth quarter and full year 2013 financial results after market closes on Thursday, February 27, 2014. Hyperion will host a webcast and conference call with management to discuss financial results, as well as provide a general corporate update, at 4:30 p.m. ET (1:30 p.m. PT).

Prime Resources Holdings, Inc. acquires additional shares in Mindoro Resources Ltd.
CNW Group - Fri Feb 21, 2:00AM CST
Prime Resources Holdings, Inc. ("PRHI" is pleased to announce that on February 14, 2014, it acquired 35,955,467 common shares ("Shares" of Mindoro Resources Ltd. ("Mindoro". Mindoro is an Edmonton, Alberta based company which is engaged in the exploration and development of mineral properties in the Philippines.

Hyperion Therapeutics to Present at the Leerink Global Healthcare Conference
GlobeNewswire - Thu Feb 06, 8:15AM CST
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Leerink Global Healthcare Conference on Thursday, February 13 at 2:40 p.m. ET.

Zoom Technologies inks intent to acquire Tinho
M2 - Thu Jan 16, 8:22AM CST
On January 13, 2014, Zoom Technologies, Inc. (NASDAQ: ZOOM) said it entered into a letter of intent with Tinho Union Holding Group to acquire all the outstanding shares of Tinho by issuing approximately 9.4 million new shares of the company's common stock at a valuation of USD8.6505 per share to the shareholders of Tinho.

Hyperion Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Wed Jan 08, 3:09PM CST
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 32 Annual J.P. Morgan Healthcare Conference on Thursday, January 16 at 7:30 a.m. PT.

Hyperion Therapeutics (HPTX) Jumps: Stock Adds 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 7:39AM CST
Hyperion Therapeutics, Inc. was a big mover last session, as its shares rose over 5% on the day.

Hyperion Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 26, 3:05PM CST
Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 25 Annual Piper Jaffray Healthcare Conference on Wednesday, December 4 at 2:00 p.m. ET.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AV Access iDock B12 Chases the Growing Two-PC Desk Boom

Updated Category News Views 136

Cable spaghetti has become an oddly durable tax on anyone running a work laptop beside a gaming tower, and AV Access is taking a proper swing at it with the iDock B12. This is not some mystical new category; it is a KVM switch and docking station mashed together for a desk that has to serve two masters. Still, the company has aimed at the parts that usually get sacrificed...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 191

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 96

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Makers Nutrition Backs Families Through Friends of Karen

Updated Category News Views 79

A thousand dollars in gift cards can look modest beside the noise of holiday marketing, but it lands differently when a family is carrying the weight of a child’s life-threatening illness. Makers Nutrition, a Hauppauge, New York-based private-label and custom supplement manufacturer, has donated $1,000 in gift cards to Friends of Karen for the nonprofit’s annual...

Continue Reading
Lieda Shadwick’s Career Education Work Earns 2026 Honor

Updated Category News Views 76

Twenty-six years in classrooms is not the sort of accomplishment that needs fireworks to carry weight. Lieda A. Shadwick’s recognition as The Inner Circle’s 2026 Educator of the Year points to a career built around a stubbornly important idea: students need more than academic vocabulary if they are going to navigate work, leadership, and business with any confidence....

Continue Reading
Ductless Mini-Splits Put HVAC Efficiency Into Focus

Updated Category News Views 46

Ductless mini-splits have slipped from contractor jargon into a serious conversation about how homes and smaller buildings are heated and cooled. That is the worthwhile backdrop for a HelloNation article featuring HVAC expert Natasha Adams. The source notes are lean—really lean—and do not spell out her specific guidance, product comparisons, efficiency figures,...

Continue Reading
Fermi Board Fight Tests Texas Governance Standards Again

Updated Category News Views 60

A boardroom rulebook is supposed to restrain power, not become a trapdoor under shareholders’ feet. That is the ugly governance question hanging over Fermi after the Texas Business Court dismissed Toby Neugebauer’s challenge to the company’s 70% supermajority bylaw. Neugebauer, Fermi’s co-founder and largest shareholder, says he will appeal. Frankly, he has every...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 134

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 101

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 105

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Investigation into iTeos Therapeutics Acquisition

Updated Category News Views 182

Investigation Overview of iTeos Therapeutics, Inc. Rowley Law PLLC is currently delving into possible violations of securities laws involving iTeos Therapeutics, Inc. (NASDAQ: ITOS) and its board of directors regarding the proposed acquisition by Concentra Biosciences, LLC. This acquisition aims to provide stockholders with $10.047 for each share they hold, accompanied by...

Continue Reading
Ares Management Joins S&P 500; Changes in SmallCap 600

Updated Category News Views 483

Ares Management Join the S&P 500 In an exciting development for investors, Ares Management (NYSE: ARES) will be joining the S&P 500 index shortly. This news comes as Kellanova (NYSE: K) has announced its acquisition by Mars Inc., which has precipitated the need for these changes in the index. Ares Management is making a mark in the financial sector and its inclusion...

Continue Reading
Berkshire Hathaway's Q3 Earnings Report: Key Insights Revealed

Updated Category News Views 113

Berkshire Hathaway's Underwhelming Third Quarter Performance Berkshire Hathaway's recent third-quarter earnings report has raised eyebrows as the results fell short of analyst predictions. The earnings per share (EPS) came in at $4.68, whereas consensus estimates were looking for $4.89. Analysts have pointed to several factors influencing this underperformance. Insurance...

Continue Reading
Multitude SE Reports 34.5% EBIT Growth in 2024

Updated Category News Views 101

Multitude SE Reports Strong Growth in 2024 Key takeaways: The company continues to perform well, maintaining a robust cash position. Group revenue has risen by 17.0%, reaching EUR 128.8 million. All business units are reporting at least double-digit revenue growth. On track to meet EBIT guidance of EUR 67.5 million (+50%) for 2024. Multitude SE, a leading European FinTech...

Continue Reading
Discover How Cboe Global Markets Has Grown Over a Decade

Updated Category News Views 241

Understanding the Growth of Cboe Global Markets Cboe Global Markets has displayed remarkable performance in the stock market over the past decade. Specifically, the company has outperformed the market by an average of 2.96% annually, resulting in a substantial annual return of approximately 14.72%. Presently, its market capitalization stands at around $26.52 billion,...

Continue Reading